Key facts
- This page summarizes Sujay Kango's Form 3 filing for INFINITY PHARMACEUTICALS, INC..
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 31 Mar 2022, 18:46.
Sujay Kango - 30 Mar 2022 Form 3 Insider Report for INFINITY PHARMACEUTICALS, INC.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 30 Mar 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 31 Mar 2022, 18:46:56 UTC
- Prior SEC filing
- 23 Nov 2021
- Next SEC filing
- 07 Jul 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Seth A. Tasker, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sujay Kango filed Form 3 for INFINITY PHARMACEUTICALS, INC. on 31 Mar 2022.
Change
- Previous filing in this sequence was filed on 23 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
No securities of the issuer were beneficially owned by Mr. Kango prior to becoming a reporting person. EXHIBIT LIST: EX-24 Power of Attorney